Skip to Content

GS UY2 425 (Propafenone hydrochloride extended release 425 mg)

Pill imprint GS UY2 425 has been identified as Propafenone hydrochloride extended release 425 mg.

Propafenone is used in the treatment of atrial fibrillation; ventricular tachycardia; atrial flutter; wolff-parkinson-white syndrome and belongs to the drug class group I antiarrhythmics. Risk cannot be ruled out during pregnancy. Propafenone 425 mg is not a controlled substance under the Controlled Substance Act (CSA).

Propafenone hydrochloride extended release
GS UY2 425
425 mg
Red & White
Prescription only
Drug Class:
Group I antiarrhythmics
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Prasco Laboratories

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.